54802-12-9

Basic information

• Product Name: 2-(2-cyanophenoxy)acetamide
• Synonyms: 2-(2-cyanophenoxy)acetamide
• CAS NO: 54802-12-9
• Molecular Formula: C₉H₈N₂O₂
• Molecular Weight: 176.17202
• Mol File: 54802-12-9.mol
• Article Data: 4

Chemical Properties

• Appearance: /Solid
• CAS DataBase Reference: 2-(2-cyanophenoxy)acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(2-cyanophenoxy)acetamide(54802-12-9)
• EPA Substance Registry System: 2-(2-cyanophenoxy)acetamide(54802-12-9)

Safety Data

• HazardClass: 6.1
• Hazardous Substances Data: 54802-12-9(Hazardous Substances Data)

Usage

Description

2-(2-cyanophenoxy)acetamide is a chemical compound with the molecular formula C10H8N2O3. It is a derivative of acetamide with a cyanophenoxy group attached to the second carbon atom. 2-(2-cyanophenoxy)acetamide is commonly used as an intermediate for the synthesis of various pharmaceuticals and agrochemicals. Its potential pharmacological and biological activities make it of interest for research and development in the pharmaceutical industry. Furthermore, its chemical structure makes it suitable for use as a building block in the synthesis of other complex organic molecules.

Uses

Used in Pharmaceutical Industry:
2-(2-cyanophenoxy)acetamide is used as an intermediate for the synthesis of various pharmaceuticals and agrochemicals. Its unique chemical structure allows it to be a key component in the development of new drugs and other therapeutic agents.
Used in Research and Development:
2-(2-cyanophenoxy)acetamide is used as a subject of research and development in the pharmaceutical industry due to its potential pharmacological and biological activities. Scientists are interested in exploring its properties and applications to create new and innovative treatments.
Used in Organic Synthesis:
2-(2-cyanophenoxy)acetamide is used as a building block in the synthesis of other complex organic molecules. Its versatile chemical structure makes it a valuable component in the creation of a wide range of organic compounds for various applications.

Upstream product

• 611-20-1 salicylonitrile 
• 683-57-8 bromo-acetic acid amide 
• 79-07-2 Chloroacetamide 

Downstream Products

• 1315325-71-3 (2R,6S,13aS,14aR,16aS,Z)-N-(cyclopropylsulfonyl)-6-(4-fluorophenylamino)-2-(2-(4-isopropoxyphenyl)benzofuro[3,2-d]pyrimidin-4-yloxy)-5,16-dioxo-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a-carboxamide 
• 1315325-52-0 (2R,6S,13aS,14aR,16aS,Z)-N-(cyclo-propylsulfonyl)-6-(4,5-dimethylthiazol-2-ylamino)-5,16-dioxo-2-(2-(4-(trifluoromethyl-)phenyl)benzofuro[3,2-d]pyrimidin-4-yloxy)-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a-carboxamide 
• 1315326-96-5 (2R,6S,13aS,14aR,16aS,Z)-N-(cyclopropylsulfonyl)-5,16-dioxo-6-thioureido-2-(2-(4-(trifluoromethyl)phenyl)benzofuro[3,2-d]pyrimidin-4-yloxy)-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a-carboxamide 
• 1315326-95-4 (2R,6S,13aS,14aR,16aS,Z)-6-amino-N-(cyclopropylsulfonyl)-5,16-dioxo-2-(2-(4-(trifluoromethyl)phenyl)-benzofuro[3,2-d]pyrimidin-4-yloxy)-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[e]pyrrol-e[1,2-a][1,4]diazacyclopentadecine-14a-carboxamide hydrochloride 
• 1195976-53-4 C₄₃H₄₇F₃N₆O₉S 
• 1315326-82-9 (2S,4R)-1-((S)-2-amino-3,3-dimethylbutanoyl)-N-((2S)-1-(cyclopropylsulfonylcarbamoyl)-2-vinylcyclopropyl)-4-(2-(4-isopropoxy-phenyl)benzofuro[3,2-d]pyrimidin-4-yloxy)pyrrolidine-2-carboxamide hydrochloride salt 
• 1315326-79-4 C₃₈H₄₃N₅O₉S 
• 1315324-53-8 methyl 2-((2S)-1-((2S,4R)-2-((2S)-1-(cyclopropylsulfonylcarbamoyl)-2-vinylcyclopropyl-carbamoyl)-4-(2-(4-(trifluoromethyl)phenyl)benzofuro[3,2-d]pyrimidin-4-yloxy-)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-ylamino)thiazole-4-carboxylate 
• 1315326-73-8 (2S,4R)-1-((S)-2-amino-3,3-dimethylbutanoyl)-N-((1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-vinylcyclopropyl)-4-(2-(4-(trifluoromethyl)phenyl)benzofuro[3,2-d]pyrimidin-4-yloxy)pyrrolidine-2-carboxamide hydrochloride 
• 1315326-72-7 C₄₂H₄₇F₃N₆O₉S 
• 1315326-71-6 (2S,4R)-N-((1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-vinylcyclopropyl)-4-(2-(4-(trifluoromethyl)phenyl)benzofuro[3,2-d]pyrimidin-4-yloxy)pyrrolidine-2-carboxamide hydrochloride 
• 1315326-70-5 C₃₆H₃₆F₃N₅O₈S 
• 1315326-80-7 (2S,4R)-N-((1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-vinylcyclopropyl)-4-(2-(4-isopropoxyphenyl)benzofuro[3,2-d]pyrimidin-4-yloxy)pyrrolidine-2-carboxamide hydrochloride 
• 1315324-63-0 (2S,4R)-N-((1R,2S)-1-(cyclopropylsulfonylcarbamoyl-)-2-vinylcyclopropyl)-1-((S)-3,3-dimethyl-2-(4-methylthiazol-2-ylamino)butanoyl)-4-(2-(4-isopropoxyphenyl)benzofuro[3,2-d]pyrimidin-4-yloxy)pyrrolidine-2-carboxamide 

Relevant articles and documents

The design, synthesis, and biological evaluation of PIM kinase inhibitors

A series of substituted benzofuropyrimidinones with pan-PIM activities and excellent selectivity against a panel of diverse kinases is described. Initial exploration identified aryl benzofuropyrimidinones that were potent, but had cell permeability limitation. Using X-ray crystal structures of the bound PIM-1 complexes with 3, 5m, and 6d, we were able to guide the SAR and identify the alkyl benzofuropyrimidinone (6l) with good PIM potencies, permeability, and oral exposure.

HCV PROTEASE INHIBITORS

This invention relates to compounds of Formula (I), (II), or (III) shown in the specification. These compounds can be used to treat hepatitis C virus infection.